Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions
Saved in:
| Title: | Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions |
|---|---|
| Authors: | Wring, Stephen1, Murphy, Gail2, Atiee, George3, Corr, Christy4, Hyman, Michele4, Willett, Michael5, Angulo, David1 David.angulo@scynexis.com |
| Source: | Journal of Clinical Pharmacology. Oct2018, Vol. 58 Issue 10, p1305-1313. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00912700 |
|---|---|
| DOI: | 10.1002/jcph.1146 |
